Industry News
Pharmaceutical Industry News
Lawmakers Target the Power of Health Insurance Giants
UnitedHealth Group, CVS Health and Cigna are battling efforts to break up their control over prescription drugs.
As AI raises the stakes, leaders…
As AI raises the stakes, leaders need more than data. They need the readiness to turn insight into action.
How GLP-1s Feed Our Sick Culture
For women, they’re a depressingly rational choice.
CureDuchenne’s “A Cure Can’t Wait”…
CureDuchenne's "A Cure Can't Wait" serves as a public service announcement reminding viewers that "the clock is ticking" for patients and families with the rare progressive disease Duchenne muscular dystrophy.
Amid an ongoing expansion of…
Amid an ongoing expansion of China’s volume-based procurement (VBP) scheme to lower drug costs, the Chinese government has singled out a fraud case involving a foreign originator drug in a warning to the industry.
After thriving in the market for…
After thriving in the market for more than a decade as the only treatment for Dupuytren's contracture and Peyronie’s disease, Keenova Therapeutics’ Xiaflex has excelled in a phase 3 trial that could set up the
After pledging earlier this year…
After pledging earlier this year to bolster its drug substance capabilities in Central Europe, German chemical company Evonik is turning its attention to the U.S.
Catalent is shedding one of its…
Catalent is shedding one of its U.K. manufacturing facilities as it inks a separate partnership deal to advance a new gene therapy, expanding in certain areas while scaling back in others.
Allergan Aesthetics on Tuesday…
Allergan Aesthetics on Tuesday welcomed Girls Inc. participants to a panel and tour at its Allergan Medical Institute in Orange County, CA.
In biopharmaceutical R&D,…
In biopharmaceutical R&D, where fewer than 1 in 10 development programs ultimately reach approval, risk assessment remains central to portfolio strategy and investment decisions.
Life sciences leaders say patient…
Life sciences leaders say patient support is falling short. New research reveals why 9 of the top 10 pharma manufacturers partner with Redi Health.
Novartis is executing more layoffs…
Novartis is executing more layoffs at its U.S. headquarters in East Hanover, New Jersey, handing 322 employees pink slips. The cuts will go into effect by Oct. 2, according to a Worker Adjustment and Retraining
As Bristol Myers Squibb attempts…
As Bristol Myers Squibb attempts to convert two accelerated oncology nods for Krazati into traditional FDA approvals, the company has detailed what could be a major stumble in the KRAS G12C inhibitor’s smaller-opportunity indication of
While not on the same scale of…
While not on the same scale of some of Big Pharma’s major carveouts in recent years, the deal follows a noticeable pattern in which diversified drugmakers have simplified their structures to focus more on innovative
When Vera Therapeutics in-licensed…
When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no FDA-approved treatment options. Today, the dual-target drug has crossed the regulatory finish line but is entering
More Americans Than Ever Are Taking Weight-Loss Drugs
The number of U.S. adults taking an obesity medication has nearly quadrupled from just two years ago.
Vertex Pharmaceuticals has struck…
Vertex Pharmaceuticals has struck a $10 billion deal—its largest ever—to acquire endocrine disease specialist Crinetics Pharmaceuticals. The transaction's two focuses, Palsonify and atumelnant, have combined peak sales potential of more than $5 billion, Vertex said.
Healthcare comms and AI marketing…
Healthcare comms and AI marketing firm Real Chemistry has set up its first Asia Pacific strategic hub in Singapore with the acquisition of Spurwing Communications.
Skin quality affects quality of…
Skin quality affects quality of life for 85% of people, leaving more than one-third of individuals feeling self-conscious, insecure or anxious, a Galderma survey found.
Heidi, alongside creative firm…
Heidi, alongside creative firm Cocogun and media agency TRG, have launched a new brand campaign that positions its AI tool as a dose of "relief, on repeat."